Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A 2a receptor antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 19, 2004, Pages 4835-4838

  Vu, Chi B ^a   Shields, Pamela ^a   Peng, Bo ^a   Kumaravel, Gnanasambandam ^a   Jin, Xiaowei ^a   Phadke, Deepali ^a   Wang, Joy ^a   Engber, Thomas ^a   Ayyub, Eman ^a   Petter, Russell C ^a  

^a BIOGEN   (United States)

Author keywords

A 2a antagonists; Catalepsy; Parkinson's disease

Indexed keywords

ADENOSINE A2A RECEPTOR ANTAGONIST; ANTIPARKINSON AGENT; ETHYLENEDIAMINE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; MOUSE; NONHUMAN; PARKINSON DISEASE; RECEPTOR BLOCKING;

ANIMALS; ANTIPARKINSON AGENTS; MICE; PYRIMIDINES; RECEPTOR, ADENOSINE A2A; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZINES; TRIAZOLES;

EID: 4444254922     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.07.048     Document Type: Article

References (25)

1. C.E. Müller Drugs of the Future 25 2000 1043
2. B.B. Fredholm, M.P. Abbraccio, G. Burnstock, J.W. Daly, T.K. Harden, K.A. Jacobson, P. Leff, and M. Williams Pharmacol. Rev. 46 1994 143
3. M.F. Jarvis, and M. Williams Eur. J. Pharmacol. 168 1989 243
4. M.I. Martinez-Mir, A. Probst, and J.M. Palacios Neuroscience 42 1991 697
5. P. Svenningsson, C. Le Moine, G. Fisone, and B.B. Fredholm Prog. Neurobiol. 59 1999 355
6. S.N. Schiffmann, O. Jacobs, and J.-J. Vanderhaeghen J. Neurochem. 57 1991 1062
7. M. Kurokawa, I.P. Kirk, K.A. Kirkpatrick, H. Kase, and P.J. Richardson Br. J. Pharmacol. 113 1994 43
8. E. Ongini, and B.B. Fredholm Trends Pharmacol. Sci. 17 1996 364
9. T. Kanda, S. Shiozaki, J. Shimada, F. Suzuki, and J. Nakamura Eur. J. Pharmacol. 256 1994 263
10. J. Shimada, N. Koike, H. Nonaka, S. Shiozaki, K. Yanagawa, T. Kanda, H. Kobayashi, M. Ichimura, J. Nakamura, H. Kase, and F.I. Suzuki Bioorg. Med. Chem. Lett. 7 1997 2349
11. S. Shiozaki, S. Ichikawa, J. Nakamura, S. Kitamura, K. Yamada, and Y. Kuwana Psychopharmacology 147 1999 90
12. R. Grondin, P.J. Bedard, T.A. Hadj, L. Gregoire, A. Mori, and H. Kase Neurology 52 1999 1673
13. T. Kanda, M.J. Jackson, L.A. Smith, R.K.B. Pearce, J. Nakamura, H. Kase, Y. Kuwana, and P. Jenner Ann. Neurol. 43 1998 507
14. 2a antagonists see: P.G. Baraldi, B. Cacciari, G. Spalluto, A. Borioni, M. Viziano, S. Dionisotti, and E. Ongini Curr. Med. Chem. 2 1995 707
15. P.G. Baraldi, B. Cacciari, R. Romagnoli, G. Spalluto, A. Monopoli, E. Ongini, K. Varani, and P.A. Borea J. Med. Chem. 45 2002 115
16. Neustadt, B. R.; Lindo, N. A.; Greenlee, W. J.; Tulshian, D.; Silverman, L. S.; Xia, Y.; Boyle, G. D.; Chackalamannil, S. WO 01/92264 A1
17. Neustadt, B. R.; Liu, H. WO 0348163
18. Tsumuki, H.; Junichi, S.; Imma, H.; Nakamura, N.; Nonaka, H.; Shiozaki, S.; Ichikawa, S.; Kanda, T.; Kuwana, Y.; Ichimura, M.; Suzuki, F. U.S. Patent 6,222,035 B1
19. Tsumuki, H.; Nakamura, A.; Shiozaki, S.; Ichimura, M.; Kuwana, Y.; Shimada, J. WO 99/43678 A1
20. Vu, C. B.; Peng, B.; Kumaravel, G.; Smits, G.; Jin, X.; Phadke, D.; Engber, T.; Huang, C.; Reilly, J.; Tam, S.; Grant, D.; Hetu, G.; Chen, L.; Zhang, J.; Petter, R. C. J. Med. Chem., in press
21. Vu, C. B.; Pan, D.; Peng, B.; Kumaravel, G.; Smits, G.; Jin, X.; Phadke, D.; Engber, T.; Huang, C.; Reilly, J.; Tam, S.; Grant, D.; Hetu, G.; Petter, R. C. J. Med. Chem., in press
22. Vu, C. B.; Pan, D.; Peng, B.; Sha, L.; Kumaravel, G.; Jin, X.; Phadke, D.; Engber, T.; Huang, C.; Reilly, J.; Tam, S.; Petter, R. C. Bioorg. Med. Chem. Lett. 2004, 14, preceding communication. doi:10.1016/j.bmcl.2004.07.047
23. C.E. Müller, M. Thorand, R. Qurishi, M. Diekmann, K.A. Jacobsen, W.L. Padgett, and J.W. Daly J. Med. Chem. 45 2002 3440
24. P.W.R. Caulkett, G. Jones, M. McPartlin, N.D. Renshaw, S.K. Stewart, and B. Wright J. Chem. Soc., Perkin Trans. 1 1995 801
25. P.R. Sanberg, N. Giordano, M.D. Bunsey, and A.B. Norman Behav. Neurosci. 102 1988 748